Related Experiment Video
Updated: May 15, 2026

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections
Published on: August 11, 2012
Antimicrobial peptide from spider venom inhibits Chlamydia trachomatis infection at an early stage
Vassili N Lazarev1, Marina M Shkarupeta, Nadezhda F Polina
1Research Institute for Physico-Chemical Medicine of the Federal Medical and Biological Agency of Russian Federation, Moscow, Russia. lazar0@mail.ru
Abstract:
Antichlamydial activity of cyto-insectotoxin 1a (CIT 1a), representative of a unique class of antimicrobial peptides from the venom of the Central Asian spider Lachesana tarabaevi, was studied. A plasmid vector expressing the cit 1a gene controlled by a human cytomegalovirus tetracycline-dependent promoter was constructed. Impressive inhibition of Chlamydia trachomatis infection in HEK 293 cells transfected by the cit 1a-harboring vector was achieved. With the use of various schemes of cell infection and gene expression induction, it was shown for the first time that an antimicrobial peptide exerts its potent antichlamydial action at an early stage of the pathogen life cycle.
Related Concept Videos
Bacterial Phylum Chlamydiae
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Sexually Transmitted Infections
Antimicrobial Effectiveness

